These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 22584762)

  • 1. Catecholaminergic polymorphic ventricular tachycardia found in an adolescent after a methylenedioxymethamphetamine and marijuana-induced cardiac arrest.
    Diffley M; Armenian P; Gerona R; Reinhartz O; Avasarala K
    Crit Care Med; 2012 Jul; 40(7):2223-6. PubMed ID: 22584762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deadly proposal: a case of catecholaminergic polymorphic ventricular tachycardia.
    Heiner JD; Bullard-Berent JH; Inbar S
    Pediatr Emerg Care; 2011 Nov; 27(11):1065-8. PubMed ID: 22068070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Description of a novel RyR2 mutation in a juvenile patient with symptomatic catecholaminergic polymorphic ventricular tachycardia in sleep and during exercise: a case report.
    Seidlmayer LK; Riediger F; Pagonas N; Nordbeck P; Ritter O; Sasko B
    J Med Case Rep; 2018 Oct; 12(1):298. PubMed ID: 30296944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia.
    Hayashi M; Denjoy I; Extramiana F; Maltret A; Buisson NR; Lupoglazoff JM; Klug D; Hayashi M; Takatsuki S; Villain E; Kamblock J; Messali A; Guicheney P; Lunardi J; Leenhardt A
    Circulation; 2009 May; 119(18):2426-34. PubMed ID: 19398665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholaminergic polymorphic ventricular tachycardia in a child: a case report.
    Garabedian L; Verryckt A; Panzer J; De Wolf D
    Acta Paediatr; 2008 Jan; 97(1):127-9. PubMed ID: 18052993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation.
    Allouis M; Probst V; Jaafar P; Schott JJ; Le Marec H
    Am J Cardiol; 2005 Mar; 95(5):700-2. PubMed ID: 15721128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac ryanodine receptor gene (hRyR2) mutation underlying catecholaminergic polymorphic ventricular tachycardia in a Chinese adolescent presenting with sudden cardiac arrest and cardiac syncope.
    Mok NS; Lam CW; Fong NC; Hui YW; Choi YC; Chan KY
    Chin Med J (Engl); 2006 Dec; 119(24):2129-33. PubMed ID: 17199967
    [No Abstract]   [Full Text] [Related]  

  • 8. A novel mutation in FKBP12.6 binding region of the human cardiac ryanodine receptor gene (R2401H) in a Japanese patient with catecholaminergic polymorphic ventricular tachycardia.
    Aizawa Y; Ueda K; Komura S; Washizuka T; Chinushi M; Inagaki N; Matsumoto Y; Hayashi T; Takahashi M; Nakano N; Yasunami M; Kimura A; Hiraoka M; Aizawa Y
    Int J Cardiol; 2005 Mar; 99(2):343-5. PubMed ID: 15749201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening.
    Haugaa KH; Leren IS; Berge KE; Bathen J; Loennechen JP; Anfinsen OG; Früh A; Edvardsen T; Kongsgård E; Leren TP; Amlie JP
    Europace; 2010 Mar; 12(3):417-23. PubMed ID: 20106799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catecholaminergic polymorphic ventricular tachycardia.
    Liu N; Ruan Y; Priori SG
    Prog Cardiovasc Dis; 2008; 51(1):23-30. PubMed ID: 18634915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel variant in RyR2 causes familiar catecholaminergic polymorphic ventricular tachycardia.
    Bosch C; Campuzano O; Sarquella-Brugada G; Cesar S; Perez-Serra A; Coll M; Mademont I; Mates J; Del Olmo B; Iglesias A; Brugada J; Petersen V; Brugada R
    Forensic Sci Int; 2017 Jan; 270():173-177. PubMed ID: 27988446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Catecholaminergic polymorphic ventricular tachycardia is a rare inherited heart disease].
    Holst AG; Tfelt-Hansen J; Olesen MS; Theilade J; Winkel BG; Christensen AH; Bundgaard H; Haunsø S; Svendsen JH
    Ugeskr Laeger; 2010 Aug; 172(31):2140-4. PubMed ID: 20670590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catecholaminergic Polymorphic Ventricular Tachycardia: The Cardiac Arrest Where Epinephrine Is Contraindicated.
    Bellamy D; Nuthall G; Dalziel S; Skinner JR
    Pediatr Crit Care Med; 2019 Mar; 20(3):262-268. PubMed ID: 30640888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel ryanodine receptor 2 mutation associated with a severe phenotype of catecholaminergic polymorphic ventricular tachycardia.
    LaPage MJ; Russell MW; Bradley DJ; Dick M
    J Pediatr; 2012 Aug; 161(2):362-4. PubMed ID: 22608700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations.
    Swan H; Laitinen P; Kontula K; Toivonen L
    J Cardiovasc Electrophysiol; 2005 Feb; 16(2):162-6. PubMed ID: 15720454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation (Arg169Gln) of the cardiac ryanodine receptor gene causing exercise-induced bidirectional ventricular tachycardia.
    Hsueh CH; Weng YC; Chen CY; Lin TK; Lin YH; Lai LP; Lin JL
    Int J Cardiol; 2006 Apr; 108(2):276-8. PubMed ID: 16517285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.
    Postma AV; Denjoy I; Kamblock J; Alders M; Lupoglazoff JM; Vaksmann G; Dubosq-Bidot L; Sebillon P; Mannens MM; Guicheney P; Wilde AA
    J Med Genet; 2005 Nov; 42(11):863-70. PubMed ID: 16272262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the diagnosis and management of Catecholaminergic Polymorphic Ventricular Tachycardia.
    Pflaumer A; Davis AM
    Heart Lung Circ; 2012 Feb; 21(2):96-100. PubMed ID: 22119737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex atrial arrhythmias as first manifestation of catecholaminergic polymorphic ventricular tachycardia: an unusual course in a patient with a new mutation in ryanodine receptor type 2 gene.
    Lawrenz W; Krogmann ON; Wieczorek M
    Cardiol Young; 2014 Aug; 24(4):741-4. PubMed ID: 23985380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia.
    Priori SG; Napolitano C; Tiso N; Memmi M; Vignati G; Bloise R; Sorrentino V; Danieli GA
    Circulation; 2001 Jan; 103(2):196-200. PubMed ID: 11208676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.